Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer

International Journal of Clinical Oncology

Volumn 9, Issue 4, 2004, Pages 317-321

  Yahata, Hideaki ^a   Hirakawa, Toshio ^a   Fujita, Takuji ^a   Ariyoshi, Kazuya ^a   Sonoda, Kenzo ^a   Amada, Satoshi ^a   Kobayashi, Hiroaki ^a   Nakano, Hitoo ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cisplatin based chemotherapy; Endometrial cancer

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; PIRARUBICIN;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INDUCED DISEASE; ENDOMETRIUM CANCER; FEMALE; HIGH RISK PATIENT; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; NEPHROTOXICITY; NEUTROPENIA; PELVIS LYMPH NODE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA;

ADENOCARCINOMA; ADULT; AGED; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYCLOPHOSPHAMIDE; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4644231914     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0400-x     Document Type: Article

References (19)

1. Mori M, Sagae S (2001) Recent progress in epidemiologic research of uterine cancer (in Japanese). Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 28:174-178
2. Creaseman WT, Odicino F, Maisonneuve P, et al. (2001) Carcinoma of the corpus uteri. J Epidemiol Biostatistics 6:47-86
3. Thigpen JT, Blessing JA, Homesley H, et al. (1989) Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 33:68-70
4. Moore TD, Phillips PH, Nerenstone SR, et al. (1991) Systemic treatment of advanced and recurrent endometrial carcinoma: current status and future prospects. J Clin Oncol 9:1071-1088
5. Muss HB (1994) Chemotherapy of metastatic endometrial cancer. Semin Oncol 21:107-113
6. Thigpen T, Vance RB, Khansur Y (1995) The platinum compounds in the management of carcinomas of the endometrium and uterine cervix. Semin Oncol 22:67-75
7. Trope C, Kristensen G (1997) Current status of chemotherapy in gynecologic cancer. Semin Oncol 24:S15-1-S15-S22
8. Lovecchio JL, Averette HE, Lichtinger M, et al. (1984) Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cisplatinum, and megesterol acetate. Obstet Gynecol 63:557-560
9. Turbow MM, Ballon SCK, Sikic BI, et al. (1985) Cisplatin, doxorubicin and cyclophosphamide chemotherapy for advanced endometrial carcinoma. Cancer Treat Rep 69:465-467
10. Hancock KC, Freedman RS, Edwards CL, et al. (1986) Use of cisplatin, doxorubicin and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium. Cancer Treat Rep 70:789-791
11. Edmondson JH, Krook JE, Hilton JF, et al. (1987) Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma. Gynecol Oncol 28:20-24
12. Hoffman MS, Roberts WS, Canavag D, et al. (1989) Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide and megestrol acetate. Gynecol Oncol 35:75-77
13. Dunton CJ, Pfeifer SM, Braitman LE, et al. (1991) Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin and cyclophosphamide. Gynecol Oncol 41:113-166
14. Burke TW, Stringer CA, Morris M, et al. (1991) Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin and cyclophosphamide. Gynecol Oncol 40:264-267
15. Ball HG, Blessing JA, Lentz SS, et al. (1996) A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 62:278-281
16. Price FV, Edwards RP, Kelley JL, et al. (1997) A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histologic high-risk endometrial carcinoma: preliminary report. Semin Oncol 24:s15-78-s15-82
17. Dimopoulos MA, Papadimitriou CA, Georgoulias V, et al. (2000) Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study. Gynecol Oncol 78:52-57
18. Ebina Y, Hareyama H, Sakuragi N, et al. (1997) Peritoneal cytology and its prognostic value in endometrial carcinoma. Int Surg 82:244-248
19. Kashimura M, Sugihara K, Toki N, et al. (1997) The significance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol Oncol 67:285-290